Australasian Society for Infectious Diseases (ASID) Annual Scientific Meeting
2021-03-24 - 2021-03-26 | Pullman Melbourne on the Park, 192 Wellington Parade, MELBOURNE, 3002, Australia
The ASID Annual Scientific Meeting is the leading Australasian meeting for adult and paediatric infectious disease and clinical microbiology specialists. The conference is an ideal opportunity for connecting clinicians, microbiologists and other health professions with a common interest in infectious diseases and provides a friendly forum for the exchange of scientific advances in the prevention, diagnosis and management of clinical infectious diseases. International speakers will offer expert global perspectives on our themes and Australasian research and expertise will be highlighted with keynote lectures, proffered papers and symposia. The main theme is “Hospital Infectious Diseases”
Click here to learn more.
Click here to view the agenda.
Click here to register.

The Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance at Tufts (Levy CIMAR) Monthly Science Meeting: Innovation Solutions to AMR
2021-03-25 12:00 - 13:00 (America/New_York) | VIRTUAL EVENT
Please join us on Thursday, March 25th, at noon for this month’s Levy CIMAR Science Meeting on “Innovation Solutions to AMR.” We are excited to hear from Kevin Outterson, Esq., Professor of Law at Boston University and Executive Director of the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X. CARB-X is a global partnership hosted at BU Law that is focused on supporting developers of promising new antibiotics, diagnostics, and vaccines that tackle the threat of untreatable bacterial infections.
CARB-X participants include Kevin Outterson, Executive Director.
Click here to learn more about Levy CIMAR.
Contact Rima Mycynek @ Rima.Mycynek@tufts.edu for Zoom Details.

Decennial Day: 6th International Conference on Healthcare Associated Infections
2021-04-12 | ME
We are excited to announce ‘Decennial Day’ which will be a complimentary program to SHEA Spring 2021. Decennial Day will feature a few selected sessions from the 2020 Decennial Program to be virtually held on April 12, 2021. More information to come on sessions and speakers at a later date.
You will automatically be registered for Decennial Day when you register for SHEA Spring 2021. If you wish to only sign up for Decennial Day (and not SHEA Spring) you may do so. Learn More
CARB-X participants include Kevin Outterson, Executive Director.
Click here to learn more.
Click here to view the agenda.
Click here to register.

SHEA Spring 2021 Conference
2021-04-13 - 2021-04-16 | VIRTUAL EVENT
Who should come to SHEA Spring 2021?
SHEA members and non-members of all disciplines relating to Infection Prevention Programs, Antibiotic Stewardship Programs, Public Health, Pharmacy, Occupational Health, Clinical Microbiology, Quality Improvement, and Patient Safety. If you are involved in infection prevention or infection control you need to be at SHEA Spring 2021!
Click here to learn more.
Click here to view the agenda.
Click here to register.

Anti-Infectives Drug Development Summit
2021-04-20 - 2021-04-22 | VIRTUAL EVENT
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
With some now considering the field as the new ‘Wall Street darling’, especially given the $1 billion launch of the AMR action fund, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs.
Bringing together 60+ senior leaders from large pharma, innovative biotech, academia and investment companies, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates, novel modalities and effective strategies, that address market sustainability and aim for superiority.
CARB-X participants include Kevin Outterson, Executive Director, who will be leading the session “Surviving FDA Approval of your Antibiotic” on Wednesday April 21 at 9:25am ET / 6:25am PDT. He will touch upon:

What can we learn from the past decade of FDA antibiotic approvals? •
Niche markets where your drug can differentiate from generics
Non-dilutive funding: CARB-X, BARDA, HERA
Exit: AMR Action Fund, PASTEUR

CARB-X funded companies participating include Peptilogics, Vedanta, Antabio, Bioversys, ContraFect, Locus, Techulon, Summit, and MicuRx.
Click here to learn more.
Click here to view the event guide.
Click here to register.

JPIAMR Therapeutics Workshop - Feeding the Antimicrobial Pipeline
2021-04-20 - 2021-04-22 | ME
As AMR emerges, new strategies for the treatment of infection and identification of resistant microbes are crucial. This JPIAMR activity, led by the UK Medical Research Council (MRC) with support from South Africa (SAMRC), Korea (NRF), France (ANR), and Canada (CIHR) is delivered as part of JPIAMR’s mission to enable global coordination of research.
The workshop “Feeding the AMR Therapeutics Pipeline” will bring together academics, industry, innovators, and policymakers to discuss the global antimicrobial development pipeline, identify gaps and opportunities for future research and development, and support collaboration for creative solutions to real-world problems facing therapeutics development in the context of antimicrobial resistance (AMR).
The workshop is organised online in three half-day sessions, (13:00-17:00 CET) from the 20th to the 22nd of April 2021, combining keynote presentations, short invited talks selected from abstract submissions, and panel discussions.
CARB-X participants include Kevin Outterson, Executive Director, who will be leading session “Session 2 Choosing wisely – is your product worth developing?” which will take place between 14:50 to 15:50 CET on April 20th.
Click here to learn more.
Click here to register.

Anti-Infectives Drug Development Summit
2021-04-20 - 2021-04-22 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
With some now considering the field as the new ‘Wall Street darling’, especially given the $1 billion launch of the AMR action fund, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs.
Bringing together 60+ senior leaders from large pharma, innovative biotech, academia and investment companies, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates, novel modalities and effective strategies, that address market sustainability and aim for superiority.
Here is a sneak peak of the world-class speaker faculty:

Cara Cassino, Executive Vice President of R&D & Chief Medical Officer, ContraFect
Kevin Outterson, Executive Director, CARB-X
Silas Holland, Head of External Affairs (Interim) & Director of Global Policy, Merck & The AMR Action Fund
David Powell, Chief Scientific Officer, Summit Therapeutics
Dave Ousterout, Chief Scientific Officer, Locus Biosciences
Angela Talley, Vice President of Clinical Development, Spero Therapeutics
Ercem Atillasoy, Chief Regulatory & Safety Officer, AlloVir
David Alterac, Chief Medical Officer, Entasis Therapeutics

Click here to learn more.
Click here to view the agenda.
Click here to register.

Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea; Public Workshop
2021-04-23 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
FDA, NIAID and CDC are announcing a public workshop regarding the development considerations of antimicrobial drugs for the treatment of gonorrhea. The workshop will focus on the current state and nonclinical and clinical trial design considerations regarding antimicrobial drug development for gonorrhea and include the following topic areas:

Animal models
Clinical pharmacology considerations
Trial design considerations for gonorrhea, such as enrollment strategies, choice of comparators and site of infection.

This meeting will be held in virtual format only. Registration is required for online attendance.
To learn more, click here.
Additional details forthcoming.

9th Annual Cystic Fibrosis Symposium 2021
2021-04-24 08:00 - 12:30 (America/Los_Angeles) | Auditorium at UCLA Medical Center, Santa Monica, 1250 16th Street, Santa Monica, CA, 90404, United States
This course is designed to increase the knowledge of managing patients with CF across the lifespan of all who interact with this population.
About this Event
The target audience includes nurses, respiratory therapists, physical and occupational therapists, social workers, dieticians, child life specialists, and physicians
Click here to learn more and register.

BactiVac Online: Virtual Network Conference 2021
2021-04-27 - 2021-04-28 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Delivering our 2021 Virtual Network Conference in an innovative online format will provide a unique opportunity to hear about the latest bacterial vaccinology research from leading international researchers in a safe environment. Talks will be delivered by a host of internationally renowned speakers from a range of disciplines, all actively involved in the research area of bacterial vaccinology. Please view the programme for our virtual conference, together with speaker profiles.
The conference is open and free to attend for BactiVac Network members only and booking is compulsory; you can apply for free membership here. Registration for the conference is now closed.
Keep up to date by following us on @BactiVac, using #BactiVacEvents. You can also download BactiVac Virtual Conference flyer to circulate and/or display within your organisation.
For any queries regarding virtual conference, please contact us at: bactivac@contacts.bham.ac.uk
Click here to learn more.

BSAC Spring Conference
2021-04-29 - 2021-04-30 | ME
Additional details forthcoming. Click here to learn more.

Live Webinar: GARDP/REVIVE – AMR R&D efforts in the CMC and formulation arena: Do it right the first time!
2021-04-29 11:00 - 12:30 (America/New_York) | Webinar
Speaker: Aleksandar Danilovski, Chief Scientific Officer, Xellia Pharmaceuticals (Denmark)
Moderator: TBC
Aleksandar’s presentation will discuss:

Are CMC and formulation efforts treated as the foster child in the innovation and development armament?
Underestimating CMC and formulation aspects can potentially cause significant delays and project failures
Appropriate (what, how and when) CMC and formulation innovation and development strategies can improve overall probability of project success, can bring competitive advantages (including IP umbrella) and can reduce time to market – Do it right the first time!

The presentation will be followed by a Q&A session.
Click here to learn more and register.

World Vaccine Congress Washington 2021
2021-05-04 - 2021-05-06 | VIRTUAL EVENT
For the past 20 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities. Our event format allows for whole-sector topics, giving an opportunity for people to find out more about their specific area of research and their job-function. By running parallel niche conference channels over the 3 days, it increases the relevance of the whole event for everyone who attends.

Cancer Immunotherapy
Immune Profiling
Respiratory Vaccines
Emerging & Infectious Diseases
Clinical Trials
Vaccine Partnerships
Bioprocessing & Manufacturing
Vaccines Safety
Logistics
Veterinary Vaccines
Partnerships

During these sessions you will learn how cutting-edge research efforts can be integrated with pharma, biotech, academia and government to produce more and better vaccines to the market.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Duke-Margolis Center for Health Policy Webinar: Combating Rising Antimicrobial Resistance (AMR) & Advancing Public Health Preparedness
2021-05-12 11:00 - 12:30 (America/New_York) | WEBINAR, Webinar, Webinar, United States
Join the Duke-Margolis Center for Health Policy—including an introduction by former FDA Commissioners Dr. Mark McClellan and Dr. Scott Gottlieb—for an important discussion on combating rising antimicrobial resistance (AMR) in the context of U.S. public health preparedness, support for novel antibiotics, global AMR policy leadership, and emerging multi-sector innovation.
Rising antimicrobial resistance remains a top global public health threat and efforts to support novel antibiotic development and availability are more critical and timely than ever. As the ongoing pandemic centers national and global conversations around actions to prevent and combat future infectious disease threats, the time to take action against AMR is now.
CARB-X participants include Kevin Outterson, Executive Director, who will join the panel for Session 2: Global Policy Leadership and Proposals to Combat AMR at 11:25AM ET. This session will highlight how the U.S. can lead policy approaches to combat AMR through existing legislative proposals and opportunities to coordinate domestic
actions with existing international efforts.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Gordon Research Conference: Structure, Dynamics and Development of Bacterial Cells
2021-06-20 - 2021-06-25 | Colby-Sawyer College, 541 Main Street, New London, NH, 03257, United States
Bacterial cells are exquisitely organized in time and space, and carry out complex decision-making, intercellular coordination, and development to thrive in diverse environments. The 2021 inaugural Bacterial Cell Biology and Development Gordon Research Conference will explore recent research into the organization, dynamics, and development of bacterial cells and communities using a breadth of experimental approaches and biological systems. Invited speakers will present work probing the fundamental cell biological mechanisms of growth and division, and of the specialized behaviors and developmental pathways bacteria engage to ensure survival in changing environments. Inclusion of research in species that span bacterial phylogeny, lifestyles, and growth niches will stimulate thought and discussions on the conservation and evolution of cell biological mechanisms in bacteria.
The 2021 Bacterial Cell Biology and Development GRC brings together a group of international scientists including cell biologists, bacteriologists, biochemists, geneticists, physicists, structural biologists, and imaging specialists to facilitate a collaborative and interdisciplinary discussion of bacterial cell biology and development. The program will comprise talks from 24 invited speakers organized into 9 thematic sessions, with an additional ~20 short talks selected from submitted abstracts. Daily poster sessions and ample free time will enable networking, collaboration, brainstorming, and other informal interactions among attendees. As a new GRC, we are not able to hold a trainee-oriented Gordon Research Seminar in conjunction with this inaugural meeting. Look for this offering in future iterations of this GRC.
Click here to learn more.
Click here to register.

World Microbe Forum
2021-06-20 - 2021-06-24 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
From new infectious pathogens like SARS-CoV-2, to antimicrobial resistance and the role of microbes in climate change, to agriculture and food microbiology, and synthetic and applied microbiology – international experts will gather for World Microbe Forum to examine, discuss and envision solutions that science can offer to solve some of the gravest concerns confronting us today.
This unique and special event, a collaboration between the American Society for Microbiology (ASM) and the Federation of European Microbiological Societies (FEMS), is bringing together two of the biggest events in the microbial sciences, ASM Microbe 2021 and FEMS2021, to further science and help answer some of the most important questions impacting humankind. Additional scientific societies, including the American Society for Virology (ASV) and the African Society for Laboratory Medicine (ASLM) will be key partners in this event.
Explore the hottest topics in microbiology, discussed like never before, and offering unparalleled access to the latest innovative research across global perspectives. Create meaningful connections with peers from around the world. Be a part of this first-of-its-kind virtual meeting uniting the microbial sciences community.
CARB-X participants include Erin Duffy, Chief of R&D, who will join a panel focused on “Advancing Collaborations in the Global Fight Against AMR and Pandemics” on June 21st from 11am to 12:30pm ET.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Sepsis Tech & Innovation 2021
2021-06-22 - 2021-06-23 | VIRTUAL EVENT
Following the success of the inaugural Sepsis Alliance Summit in 2020, Sepsis Alliance is proud to announce the inaugural Sepsis Tech & Innovation virtual conference. Engage with the nation’s leading innovators, clinicians, investors, and policymakers to discuss health technology and innovation, and its tremendous potential to reduce the burden of sepsis.
Catapulting off of Sepsis Alliance’s successful 2020 Sepsis Alliance Summit with more than 4,000 registered attendees, Sepsis Tech and Innovation is a very exciting opportunity for Sepsis Alliance to expand its voice in the health innovation and technology space. Our ultimate goal is to help take the costly guesswork out of sepsis diagnosis and care. In addition to education and training, technology and innovation are critical to achieving major progress in reducing the burden of sepsis, both in terms of lives lost and resources spent. Sepsis may be the best opportunity to leverage tech and innovation to save lives and reduce health spending in the nation. Sepsis Alliance is proud to offer Sepsis Tech & Innovation at no charge to participants.
CARB-X participants include Erin Duffy, Chief of Research and Development, who will be leading the session “Therapeutics: Innovation and Challenges in the Fight Against AMR” on June 23, 12:40pm – 1:10pm ET.
Click here to learn more.
Click here to register.

Promoting Innovative Antibiotic R&D in Switzerland
2021-06-24 | Ort Hotel ODELYA, Missionstr. 21, Basel, CH-4055, Switzerland
The event “Promoting Innovative Antibiotic R&D in Switzerland” brings together protagonists of Antibiotic Research and Development from academic, industrial, political and funding organizations active in Switzerland.
Its objective is discussing ways to facilitate technology transfer from academia to an industrial setting and to further the development of an attractive ecosystem, at national and international level, for bringing new antibiotics to the market.
Initially planned for March 2020 and postponed due to COVID-19, this gathering of the Antibiotic R&D community is all the more anticipated to give impulses to the field on 24th June 2021!
June 24th, 2021 l Ort Hotel ODELYA, Missionstr. 21, CH-4055 Basel
Click here to learn more.
Click here to view the agenda.
Click here to register.

Gordon Research Conference: Antimicrobial Host Defense Peptides: Biological Functions, Mechanisms of Action and Therapeutic Intervention
2021-06-26 - 2021-06-27 | Four Points Sheraton / Holiday Inn Express, 1050 Schooner Drive, Ventura, CA, United States
The Gordon Research Seminar on Antimicrobial Peptides is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
Antimicrobial Host Defense Peptides have been implicated in infection, inflammation, cancer and autoimmunity. As such, the 2021 Gordon Research Seminar on Antimicrobial Peptides will focus on the biological function and mechanisms of action of these peptides in health and disease, and how their properties can be exploited to provide therapeutic intervention.
This GRS will be held in conjunction with the “Antimicrobial Peptides” Gordon Research Conference (GRC). Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page for more information.
Click here to learn more.
Click here to register.

8th International Human Microbiome Congress (IHMC 2020)
2021-06-27 - 2021-06-29 | VIRTUAL EVENT
In June 2021, the 8th International Human Microbiome Consortium Meeting will include a fully digital format. By doing this we can ensure compliance of healthy and safety measures, and we can guarantee participation from our delegates.
With the support of the IHMC board, a strong local Organizing Committee and a Scientific Committee composed of the most renowned scientists and researchers in the Microbiota field, the Congress expects to attract a large international audience of over 1,000 delegates.
The program will include the latest scientific developments and a variety of activities of interest for early stage to senior researchers, clinical professionals, academia, the industry as well as the general public. Commercial stands will be also featured for the duration of the congress to foster networking and commercial opportunities among companies and delegates attending the event. The event will be accredited to provide Credits for Continuing Medical Education (EACCME) and will be structured around plenary sessions in the morning and parallel sessions, symposia and satellite events for companies in the afternoon.
The event will also include the 7th edition of the Barcelona Debates on the Human Microbiome, from microbes to human, a meeting where the most recent studies on the complex human-microbiome relationship and how the microbiome can influence in improving the clinical practices are discussed.
The day the Congress starts, Saturday 27th of June, coincides with the World Microbiome Day. To celebrate this day, a variety of activities will be organized and will be open to the general public to broaden their awareness of the microbiome and their effects.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Gordon Research Conference: Antimicrobial Peptides
2021-06-27 - 2021-07-02 | Four Points Sheraton / Holiday Inn Express, 1050 Schooner Drive, Ventura, CA, 93001, United States
Additional details forthcoming.
Click here to learn more.
Click here to register.

ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance
2021-06-29 - 2021-06-30 | VIRTUAL EVENT
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antibiotics and Antibiotic Resistance. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antibiotics and Antibiotic Resistance
Click here to learn more.
Click here to view the agenda.
Click here to register.

6th Microbiome Movement - Drug Development Summit
2021-06-29 - 2021-07-01 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Welcome to the 6th Microbiome Movement – Drug Development Summit, the most comprehensive forum for microbiome drug developers, the Microbiome Movement!
Continuing to unite the most forward thinking and industry researchers from the biopharmaceutical industry, our unrivaled program will uncover microbiome functionality and mechanisms, advance clinical development, overcome the key CMC challenges, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes. This is THE must attend conference for microbiome drug developers.
Recent clinical successes within the space are paving a way for the first FDA approved microbiome therapeutic, however, there still remains a number of unique scientific and practical challenges that must be overcome to pursue the causal role of the microbiome in disease, and translate the complex science into realized and effective therapies that improve patient outcomes.
Our end-to-end discussion will unite 65+ expert speakers and 250+ key decision-makers to provide you with valuable insights into the latest scientific discoveries and industry progress, to help overcome the obstacles holding back therapeutic approval. This summit provides unique a platform for lasting connections with leaders at the cutting edge of making microbiome therapeutics an effective reality.
The 6th Microbiome Movement – Drug Development Summit is the perfect opportunity for the industry to take a collaborative approach to close the clinical gap, discover the next generation of microbiome-based therapeutics, and establish new partnerships to accelerate your research.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Virtual Public Meeting
2021-06-29 - 2021-06-30 | VIRTUAL EVENT
The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice, information, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of U.S. government activities related to combating antibiotic-resistant bacteria.

At the June 29-30, 2021 Virtual Public Meeting, the PACCARB will deliberate and vote on two reports to transmit to the Secretary of Health and Human Services, the first from the Disparities in Antibiotics Access and Use Working Group, and the second from the Working Group on Antimicrobial Resistance (AMR) in Inter-Professional Education. The remainder of the 2-day public meeting will include an update on the status of the antibiotic development pipeline and an open council discussion on provocative questions in AMR (no recommendations will be made), in addition to presentations on Operationalizing One Health and the Environmental Dimensions of AMR.
Date and Time:
June 29, 2021 | 10:00 a.m. – 3:00 p.m. ET
June 30, 2021 | 10:00 a.m. – 3:00 p.m. ET

CARB-X participants include Kevin Outterson, Executive Director, who will be leading a session titled “THE ANTIBIOTICS PIPELINE: PAST, PRESENT, AND FUTURE” on June 29th at 12.05pm ET.
Click here to learn more.
Click here to view the agenda.
Click here to view a live stream of the event.

Advances in Antimicrobial Innovation Scientific meeting
2021-07-05 08:00 - 12:00 (America/New_York) | VIRTUAL EVENT
This Royal Society conference will bring together scientists, medical practitioners and funding bodies to raise awareness and interest for new anti-microbial advances.
Anti-microbial resistance continues to grow as a worldwide health challenge. Pathogens are continually evolving to combat drugs given to treat potentially life-threatening diseases, rendering treatments ineffective and threatening the many advances in fighting microbes over recent decades.
As therapeutics in current use become less effective, new approaches are required. This event aims to raise awareness and interest for new anti-microbial advances, the challenges faced in market delivery, and their appropriate use in healthcare systems.
About the conference series:
The conference is part of the Royal Society’s Transforming our future conferences in the life sciences, supported by AstraZeneca. These meetings are unique, high-level events that address the scientific and technical challenges of the next decade. Each conference features cutting edge science from industry and academia and brings together leading experts from the scientific community, including regulatory, charity and funding bodies. This conference also forms part of the Academy of Medical Sciences’ FORUM programme.
CARB-X participants include Erin Duffy, Chief of R&D, who will participate in the session ‘Challenges of prescribing, diagnostics and antibiotic education, investment and building a business model for new antibiotics’ between 3.30pm – 4.30pm EST.
Click here to learn more.
Click here to register.

31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
2021-07-09 - 2021-07-12 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
We invite you to the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will take place in Vienna, Austria and virtually from 9 – 12 July 2021. This is the first time the event will take place in summer. ECCMID, the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from relevant fields to present the latest findings and developments and share their expertise. The congress will take place in the beautiful city of Vienna at the Reed Messe Conference Centre, as well as online, allowing us to create a unique experience to all delegates regardless of the mode of participation. The programme committee has developed a multi-faceted programme to incorporate all of the exciting educational, social and professional events that ECCMID has to offer.
To learn more, click here.
To view the program, click here.
To register, click here.

BSAC and LP Webinar: Diagnostic driven strategies for antimicrobial resistance in the UK
2021-07-20 16:30 - 18:00 (Europe/London) | WEBINAR, Webinar, Webinar, United States
BSAC Infection Clinical Dilema Series
Webinar: Diagnostic driven strategies for antimicrobial resistance in the UK

Longitude Prize is partnering with British Society for Antimicrobial Chemotherapy (BSAC) for the Infection Clinical Dilemmas webinar series. It will bring diagnostic developers together with clinicians and professional bodies working on diagnostic evaluation in and for the National Health Service (NHS) in the UK, to build an understanding of the NHS commissioning path for AMR diagnostic tests. The event will include presentations by the Head of AMR at NHS England and National Institute for Health and Care Excellence (NICE), followed by an interactive ‘Ask an Expert’ session – with experts from Medicines and Healthcare products Regulatory Agency (MHRA), University of Oxford NIHR Community Healthcare MedTech and IVD Cooperative and clinicians – for developers to express challenges they face and ask questions about marketing access in the UK.

The webinar will take place on Tuesday 20th July, 1630-1800hrs BST
Click here to sign-up and register.

Innovations for Tackling Tuberculosis in the Time of COVID-19: A Two-Part Virtual Workshop
2021-07-22 11:00 - 13:00 (America/New_York) | VIRTUAL EVENT
Register now: Innovations for Tackling Tuberculosis in the Time of COVID-19: Part One of a Two-Part Workshop (July 22, 11 AM – 1 PM ET)
This public workshop is the first in a two-part series that examines the innovations needed to meet the targets for ending tuberculosis (TB) set by the WHO End TB Strategy for 2030 and affirmed by the United Nations High-Level Meeting on the Fight Against Tuberculosis. The workshop will feature presentations and discussions that will consider emerging technologies in diagnostic testing and vaccine development, improvements in TB treatment, and how to ensure increased and sustained commitments to reach the goal of ending TB in high burden countries despite the challenges from COVID-19.
This first session will provide an update on the current status, unmet needs, and promising advances in diagnostics, vaccines and therapeutics, and the critical need for new business models in sustainably combating TB.
CARB-X participants include Kevin Outterson, Executive Director, who will be a speaker during the workshop.

Click here to learn more.
Click here to view the agenda.
Click here to register.

Gordon Research Conference: Staphylococcal Diseases
2021-08-15 - 2021-08-20 | Grand Summit Hotel at Sunday River, 97 Summit Road, Newry, ME, United States
The description for this conference is being developed by the conference chairs. Please check back regularly for updates to this information.
Click here to learn more.

The World Economic Forum Special Annual Meeting - 2021 Singapore
2021-08-17 08:00 - 2021-08-21 17:00 (America/New_York) | Singapore
The World Economic Forum Special Annual Meeting 2021 in Singapore will convene on 17-20 August. The meeting follows the success of the Forum’s virtual Davos Agenda in January, which brought together world leaders from government, business and society.

The Special Annual Meeting 2021 was scheduled for 25-28 May. Although the World Economic Forum and Government of Singapore remain confident of the measures in place to ensure a safe and effective meeting, and local transmission of COVID-19 in Singapore remains at negligible levels, the change to the meeting’s timing reflects the international challenges in containing the pandemic. Current global travel restrictions have made planning difficult for an in-person meeting in the first half of the year. Furthermore, differing quarantine and air transport regulations have increased the lead time necessary to ensure that participants globally can make arrangements to join.

The Special Annual Meeting 2021 in Singapore in August will be the first global leadership summit to address the challenges of recovering from the pandemic and laying the basis for a more inclusive and sustainable world. It will bring leaders face-to-face to focus on shaping solutions to the most pressing challenges of our times.

“A global leadership summit needs the participation of all global stakeholders,” said Klaus Schwab, Founder and Executive Chairman of the World Economic Forum. “The Special Annual Meeting in Singapore in August will provide the place for leaders from business, government and civil society to come together to address the steps for global recovery.”

Click here to learn more.
